业绩和我预期差不多。看来之前跑路是对的,虽然没跑在高点[捂脸]
2022 Financial Guidance
10x Genomics expects full year 2022 revenue to be in the range of $600 million to $630 million, representing 22% to 28% growth over full year 2021 revenue. 网页链接
2021 Financial Guidance 10x Genomics expects full year 2021 revenue to be in the range of $480 million to $500 million, representing 61% to 67% growth over full year 2020 revenue.
网页链接
公布2021年和2021Q4业绩,盘后超跌22%[吐血] $10x Genomics(TXG)$ 网页链接 网页链接 @Spica: 回复@JZee: 我本来计划少量买点,但看到内部人士在卖,准备再等等。2.11,内部交易: 2022-02-08,CEO,Saxonov Serge ,卖出,12000普通股, $89.90;内部交易: 2022-02-08,CEO,Saxonov Serge ,期权,3038普通股, $11.48[滴汗]